Angiotensin receptor neprilysin inhibitor in chronic heart failure and comorbidity management: Indian consensus statement.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sanjay,Mittal

第一单位： Clinical and Preventive Cardiology, Cardiac Care, Medanta-The Medicity Hospital, Sector 38, Gurugram, Haryana 122001, India.

作者： Sanjay,Mittal ^[1] ; Sivadasanpillai,Harikrishnan ^[2] ; Anoop,Gupta ^[3] ; Sandeep,Bansal ^[4] ; George A,Koshy ^[5] ; Padhinhare P,Mohanan ^[6] ; Debdatta,Bhattacharya ^[7] ; Prafulla,Kerkar ^[8] ; Ajay,Swamy ^[9] ; Vinayak,Aggarwal ^[10] ; Sameer,Srivastava ^[11] ; Ajay,Mahajan ^[12] ; Ashwani,Mehta ^[13] ; Kamal,Sharma ^[14] ; Sadanand,Shetty ^[15]

作者单位： Clinical and Preventive Cardiology, Cardiac Care, Medanta-The Medicity Hospital, Sector 38, Gurugram, Haryana 122001, India. ^[1] Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India. ^[2] Epic Multispeciality Hospital, Ahmedabad, Gujarat, India. ^[3] Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, Delhi, India. ^[4] Cosmopolitan Hospital, Trivandrum, Kerala, India. ^[5] Department of Cardiology, Westfort Hi-Tech Hospital, Thrissur, Kerala, India. ^[6] Narayana Hrudayalaya Hospital, Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, West Bengal, India. ^[7] Asian Heart Institute, Mumbai, Maharashtra, India. ^[8] KIMS Hospital, Hyderabad, Telangana, India. ^[9] Department of Non-Invasive and Clinical Cardiology, Fortis Memorial Research Institute, Fortis Hospital, Gurgaon, Haryana, India. ^[10] Max Hospital, New Delhi, Delhi, India. ^[11] Department of Cardiology, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, Maharashtra, India. ^[12] Sir Gangaram Hospital, New Delhi, Delhi, India. ^[13] Sal Hospital, Ahmedabad, Gujarat, India. ^[14] Sadanand Healthy Living Center, Mumbai, Maharashtra, India. ^[15]

关键词 ARNI chronic heart failure chronic kidney disease sacubitril/valsartan type 2 diabetes mellitus

主题词人类(Humans);心力衰竭(Heart Failure);血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);共病现象(Comorbidity);脑啡肽酶(Neprilysin);联苯化合物(Biphenyl Compounds);复方合剂(Drug Combinations);多数赞同(Consensus);慢性病(Chronic Disease);治疗结果(Treatment Outcome);印度(India);糖尿病, 2型(Diabetes Mellitus, Type 2);高血压(Hypertension);肾功能不全, 慢性(Renal Insufficiency, Chronic);肥胖症(Obesity);危险因素(Risk Factors)

DOI 10.1177/17539447241301959

PMID 39641242

发布时间 2024-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in cardiovascular disease

17539447241301959页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Angiotensin receptor neprilysin inhibitor in chronic heart failure and comorbidity management: Indian consensus statement.

Therapeutic advances in cardiovascular disease

相似文献

Therapeutic advances in cardiovascular disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Angiotensin receptor neprilysin inhibitor in chronic heart failure and comorbidity management: Indian consensus statement.

Therapeutic advances in cardiovascular disease

相似文献

Therapeutic advances in cardiovascular disease

相关期刊

检索历史清除